NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Gurtner, Aymone ^a   Fuschi, Paola ^a   Magi, Fiorenza ^a   Colussi, Claudia ^b   Gaetano, Carlo ^b   Dobbelstein, Matthias ^c   Sacchi, Ada ^a   Piaggio, Giulia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c University of Göttingen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); HISTONE; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; MYOGENIN; NUCLEAR FACTOR Y; PROTEIN P300; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; RNA POLYMERASE II; SERINE; CCAAT BINDING FACTOR; HISTONE ACETYLTRANSFERASE PCAF; MESSENGER RNA;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HELA CELL; HETEROCHROMATIN; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MOLECULAR MECHANICS; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE REPEAT; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CONFORMATION; EUCHROMATIN; GENETIC EPIGENESIS; GENETICS; METABOLISM; METHYLATION; PROTEIN BINDING; PROTEIN TRANSPORT;

MUS;

ANIMALS; CCAAT-BINDING FACTOR; CELL PROLIFERATION; EPIGENESIS, GENETIC; EUCHROMATIN; HELA CELLS; HISTONES; HUMANS; METHYLATION; MICE; MITOSIS; MODELS, GENETIC; NUCLEIC ACID CONFORMATION; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN TRANSPORT; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 44349142307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002047     Document Type: Article

References (61)

1. Ehrenhofer-Murray AE (2004) Chromatin dynamics at DNA replication, transcription and repair. Eur J Biochem 271(12): 2335-2349.
2. Fischle W, Wang Y, Allis CD (2003) Historic and chromatin cross-talk. Curr Opin Cell Biol 15(2): 172-183.
3. Li B, Carey M, Workman JL (2007) The Role of Chromatin during Transcription. Cell 128(4): 707-719.
4. Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403: 41-45.
5. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4): 823-37.
6. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447(7143): 407-12.
7. Miao F, Natarajan R (2005) Mapping Global Histone Methylation Patterns in the Coding Regions of Human Genes. Mol Cell Biol 25(11): 4650-4661.
8. Peterson CL, Laniel MA (2004) Histories and histone modifications. Curr Biol 14(14): R546-551.
9. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, et al. (2007) UTX and JMJD3 are historic H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007 Aug 22.
10. Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sckhri R, et al. (2004) A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. The EMBO Journal 23: 605-615.
11. Meshorer E, Misteli T (2006) Chromatin in pluripotent embryonic stern cells and differentiation. Nat Rev Mol Cell Biol 7: 540-6.
12. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, et al. (2007) Polycomb-mediated methylation on Lys27 ofhistone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39(2): 232-236.
13. Brehm A, Kouzarides T (2000) Regulation of E2F1 activity by acetylation. EMBO J 19(4): 662-671.
14. Glozak MA, Sengupta N, Zhang X, Seto E (2005) Acetylation and deacetylation of non-histone proteins. Gene 363(19): 15-23.
15. Amati B, Frank SR, Donjerkovic D, Taubert S (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: 135-145.
16. Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, et al. (2006) Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 10(3): 191-202.
17. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B (2001) Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes & Development 15: 2096-2082.
18. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, et al. (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol 8(7): 764-770.
19. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, et al. (2001) Rb targets histone H3 methylation and HPI to promoters. Nature 412(6846): 561-565.
20. Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, et al. (2004) E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol Cell Biol. 24(10): 4546-4556.
21. Caretti G, Motta MC, Mantovani R (1999) NF-Y associates H3-H4 tetramers and octamers by multiple mechanisms. Mol Cell Biol 19: 8591-8603.
22. Mantovani R (1998) A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res 26(5): 1135-1143.
23. Romier C, Cocchiarella F, Mantovani R, Moras D (2003) The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J Biol Chem 278: 1336-1345.
24. Bolognese F, Wasner M, Dohna CL, Gurtner A, Ronchi A, et al. (1999) The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene 18: 1845-1853.
25. Farina A, Manni I, Fontemaggi G, Tiainen M, Cenciarelli C, et al. (1999) Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene 18: 2818-2817.
26. Hu Q, Maity SN (2000) Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes. J Biol Chem 275: 4435-4444.
27. Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, et al. (2005) Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/ M promoters. Mol Cell Biol 25(9): 3737-3751.
28. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, et al. (2001) NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem 276(8): 5570-5576.
29. Matsui T, Katsuno Y, Inoue T, Fujita F, Joh T, et al. (2004) Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J Biol Chem 279(24): 25093-25100.
30. Matuoka K, Yu Chen K (1999) Nuclear factor Y (NF-Y) and cellular senescence. Exp Cell Res 253(2): 365-371.
31. Okamura H, Yoshida K, Sasaki E, Morimoto H, Haneji T (2004) Transcription factor NF-Y regulates mdrl expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells. Int J Oncol 25(4): 1031-1037.
32. Ru Lee W, Chen CC, Lu S, Safe S (2006) 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. J Cell Biochem 99(1): 209-220.
33. Sciortino S, Gurtner A, Day A, Sacchi A, Ozato K, et al. (2001) The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep 2(11): 1018-23.
34. Van Ginkel PR, Hsiao KM, Schjerven H, Farnham PJ (1997) E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem 272: 18367-18374.
35. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y (2003) Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13: 773-780.
36. Linhart C, Elkon R, Shiloh Y, Shamir R (2005) Deciphering transcriptional regulatory elements that encode specific cell cycle phasing by comparative genomics analysis. Cell Cycle 4(12): 1788-1797.
37. Geskovic M, Chaivorapol C, Gaspar-Maia A, Li H, Ramalho-Santos M (2007) Systematic identification of cis-regulatory sequences active in mouse and human embryonic stem cells. PLoS Genet 3(8): 145.
38. Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, et al. (2003) The B Subunit of the CCAAT Box Binding Transcription Factor Complex (CBF/NF-Y) Is Essential for Early Mouse Development and Cell Proliferation. Cancer Research 63: 8167-8172.
39. Currie RA (1998) NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J Biol Chem 273: 1430-1434.
40. Jin S, Scotto KW (1998) Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 18(7): 4377-4384.
41. Li Q, Herrler M, Landsberger N, Kaludov N, Ogryzko VV, et al. (1998) Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J 17: 6300-6315.
42. Peng Y, Stewart D, Li W, Hawkins M, Kulak S, et al. (2007) Irradiation modulates association of NF-Y with Histone-modifying cofactors PCAF and HDAC. Oncogene jun 18.
43. Salsi S, Caretti G, Wasner M, Reinhard W, Haugwitz U, et al. (2003) Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J Biol Chem 278: 6642-6650.
44. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R (2003) Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 278: 30435-30440.
45. Gurtner A, Manni I, Fuschi P, Mantovani R, Guadagni F, et al. (2003) Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. Mol Biol Cell 14: 2706-2715.
46. Wansink DG, Schul W, Van der Kraan I, Van Steensel B, Van Driel R, et al. (1993) Fluorescent Labeling of Nascent RNA Reveals Transcription by RNA Polymerase II in Domains Scattered Throughout the Nucleus. J Cell Biol 122: 283-293.
47. Eun-JungCho (2007) RNA polymerase II carboxy-terminal domain with multiple connections. Exp Mol Med 39(3): 247-254.
48. Lachner M, Jenuwein T (2002) The many faces of histone lysine methylation. Curr Opin Cell Biol 14: 286-298.
49. Bannister AJ, Zegerman P, Partridge JF, Miska FA Thomas JO, et al. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain. Nature 410: 120-124.
50. Rando TA, Blau HM (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125(6): 1275-1287.
51. Park S-H, Yu G-R, Kim W-H, Moon W-S, Kim J-H, et al. (2007) NF-Y-Dependent Cyclin B2 Expression in Colorectal Adenocarcinoma. Clin Cancer Res 13(3): 858-867.
52. Mantovani R, Li XY, Pessara U, Hooft van Huijsduijnen R, Benoist C, et al. (1994) Dominant negative analogs of NF-YA. J Biol Chem 269: 20340-20346.
53. Wienche JK, Zheng S, Morrison Z, Yeh R-F (2007) Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene. Oct 29; [Epub ahead of print].
54. Bulfield G, Siller WG, Wight PA, Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189-1192.
55. de Wit E, Greil F, van Steensel B (2007) High-resolution mapping reveals links of HP1 with active and inactive chromatin components. PLoS Genet 3(3): 346-357.
56. Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, et al. (2005) Trichostatin A induces transforming growth factor beta type II receptor promoter activity and accrylation of Spl by recruitment of PCAF/ p300 to a Sp LNF-Y complex. J Biol Chem 280(11): 10047-10054.
57. Bernstein BE, Mikkelsen TS, Xie X, Karnal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2): 315-326.
58. Spivakov M, Fisher AG (2007) Epigenetic signatures of stem-cell identity. Nat Rev Genet 8(4): 263-271.
59. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, et al. (2006) The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66(10): 5330-5337.
60. Knoepfler PS, Zhang XY, Cheng PF, Galken PR, McMahon SB, et al. (2005) Myc influences global chromatin structure. EMBO J 25(12): 2723-2734.
61. Haukenes G, Kalland K-H (1998) Labelling of Eukaryotic RNA Transcripts With BrUTP Using a Non-Liposomal Tranfection Reagent (FuGENE(TM)6): New Application for Transfection Reagent. Biochemica 3: 45-46. https://www.roche-applied-cience.com/techresources/app_supp.jsp?id= 010900.